Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Thomas Hofstaetter is joining VaxInnate as chief operating officer, where he will be responsible for business development, finance and HR. For the past five years, he headed corporate business development at Wyeth and, before that, worked at Aventis, where he was senior vp for corporate development.

Dendreon hired Hans Bishop as chief operating officer;
Biogen Idec named William Young as chairman;
BioCryst Pharmaceuticals elected Charles Sanders to its board;
Genzyme appointed Bob Bertolini to its board;
BiPar Sciences named Hoyoung Huh as chairman;
Infinity Pharmaceuticals named Adelene Perkins as ceo and president;
PharmaNet has appointed Stephen Kasay as its chief information officer;
UniPhar appointed Gerard Rabbette as chief executive officer;
Eucodis Bioscience promoted Thomas Fischer chief executive officer;
Lundbeck named Sean Nolan chief executive of its US unit;
Vertex Pharmaceuticals hired Nancy Wysenski as exec vp and chief commercial officer.

Ladder thx to Flickr Creative Commons Robert CB